表观遗传与miRNA在抑郁症中的作用

doi:10.3760/cma.j.issn.1007-1245.2023.13.002

国际医药卫生导报 ›› 2023, Vol. 29 ›› Issue (13): 1782-1786.DOI: 10.3760/cma.j.issn.1007-1245.2023.13.002

表观遗传与miRNA在抑郁症中的作用

陈冠宏于茗子方雨涵程雪峰李奇李晨

滨州医学院第一临床医学院，滨州　256699

收稿日期:2023-02-08 出版日期:2023-07-01 发布日期:2023-07-21
通讯作者: 李晨，Email：lc_0625@163.com
基金资助:
国家自然科学基金青年基金项目（81601189）

Roles of epigenetics and miRNA in depression

Chen Guanhong, Yu Mingzi, Fang Yuhan, Cheng Xuefeng, Li Qi, Li Chen

First Clinical Medical School, Binzhou Medical University, Binzhou 256699, China

Received:2023-02-08 Online:2023-07-01 Published:2023-07-21
Contact: Li Qi, Email: lc_0625@163.com
Supported by:
Youth Fund of National Natural Science Foundation of China (81601189)

摘要/Abstract

摘要：

抑郁症是一种常见的情感障碍性精神疾病，以连续且长期的心情低落为主要临床特征，是现代人心理疾病最重要的类型之一。微RNA（miRNA）的表达失调与包括癌症和精神相关疾病在内的多种人类疾病有关，并且miRNA在抑郁症发病与抗抑郁治疗中起重要作用。表观遗传学是DNA序列不发生改变而产生长时程可遗传基因功能变化的生物学现象，其主要内容包括DNA甲基化、组蛋白修饰和miRNA调控等。很多研究表明，表观遗传学修饰失调是阐明抑郁症发病机制的关键。本文对近几年抑郁症表观遗传学发病机制以及miRNA在抑郁症中作用的研究进展进行综述，以期为抑郁症的发病机制的研究和治疗提供参考。

关键词:

抑郁症, 表观遗传, miRNA, DNA甲基化, 组蛋白修饰, 综述

Abstract:

Depression, one of the most important types of modern mental illness, is a common emotional disorder with continuous and long-term depression as its main clinical feature. Recent studies have shown that dysexpression of miRNA is associated with a variety of human diseases, including cancer and psychology-related diseases, and miRNA plays an important role in the pathogenesis of depression and antidepressant treatment. Epigenetics refers to the biological phenomenon of long-term heritable gene function changes without changes in DNA sequence, including histone modification, DNA methylation, and miRNA regulation. Many studies have shown that dysregulation of epigenetic modification is the key to elucidating the pathogenesis of depression. This paper reviews the recent progress in epigenetic pathogenesis of depression and the role of miRNA in depression, in order to provide reference for the pathogenesis study and treatment of depression.

Key words:

Depression, Epigenetics, miRNA, DNA methylation, Histone modification, Review

陈冠宏于茗子方雨涵程雪峰李奇李晨.

表观遗传与miRNA在抑郁症中的作用 [J]. 国际医药卫生导报, 2023, 29(13): 1782-1786.

Chen Guanhong, Yu Mingzi, Fang Yuhan, Cheng Xuefeng, Li Qi, Li Chen.

Roles of epigenetics and miRNA in depression [J]. International Medicine and Health Guidance News, 2023, 29(13): 1782-1786.

参考文献

[1] Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030 [J]. PLoS Medicine, 2006, 3(11): e442. DOI: 10.1371/journal.pmed.0030442.
[2] Friedrich MJ. Depression is the leading cause of disability around the world[J]. JAMA, 2017, 317(15): 1517. DOI: 10.1001/jama.2017.3826.
[3] Ladd-Acosta C, Fallin MD. The role of epigenetics in genetic and environmental epidemiology[J]. Epigenomics, 2016, 8(2): 271-283. DOI:10.2217/epi.15.102.
[4] Chistiakov DA, Bobryshev YV, Chekhonin VP. Epigenetic alterations in DNA and histone modifications caused by depression and antidepressant drugs: lessons from the rodent models[J]. Curr Pharm Des, 2017, 23(44): 6828-6840. DOI: 10.2174/1381612823666171031110734.
[5] Kawatake-Kuno A, Murai T, Uchida S. The molecular basis of depression: implications of sex-related differences in epigenetic regulation[J]. Front Mol Neurosci, 2021, 14: 708004. DOI: 10.3389/fnmol.2021.708004.
[6] 姚开云,丁虹琬,曹琳玉,等. 组蛋白去乙酰化酶抑制剂的抗抑郁前景[J]. 药学学报,2021,56(1): 29-36. DOI: 10.16438/j.0513-4870.2020-1217.
[7] 李海燕,伏箫燕,崔婷,等. 组蛋白乙酰化调控异常与大鼠抑郁行为的关系研究[J]. 中国药理学通报,2017,33(1): 52-57,58. DOI: 10.3969/j.issn.1001-1978.2017.01.010.
[8] 张欢,郭改艳,黄娜,等. 染色域Y样蛋白介导的组蛋白巴豆酰化与抑郁小鼠模型中NGF和炎症因子水平及神经功能紊乱的关系[J]. 现代生物医学进展,2022,22(13): 2422-2426. DOI: 10.13241/j.cnki.pmb.2022.13.004.
[9] Alural B, Genc S, Haggarty SJ. Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: past, present, and future[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2016, 73: 87-103. DOI: 10.1016/j.pnpbp.2016.03.010.
[10] 李金艳. 舍曲林对产后抑郁患者的效果及外周血相关miRNA表达与神经递质水平的影响[J]. 国际精神病学杂志,2021,48(5): 836-839.
[11] 孔令明,姚高峰,何明骏,等. 抗抑郁药对自杀意念的影响及其与miRNA表达水平的关系[J]. 解放军预防医学杂志,2019,37(7): 9-11,15.
[12] 徐小红,余正和,李静,等. miRNA132在抑郁症患者及慢性不可预知温和应激抑郁模型大鼠中的表达[J]. 中国医学科学院学报,2020,42(5): 573-577. DOI: 10.3881/j.issn.1000-503X.12958.
[13] Yuan H, Mischoulon D, Fava M, et al. Circulating microRNAs as biomarkers for depression: many candidates, few finalists[J]. J Affect Disord, 2018, 233: 68-78. DOI: 10.1016/j.jad.2017.06.058.
[14] Kocerha J, Dwivedi Y, Brennand KJ. Noncoding RNAs and neurobehavioral mechanisms in psychiatric disease[J]. Mol Psychiatry, 2015, 20(6): 677-684. DOI: 10.1038/mp.2015.30.
[15] Shi Y, Wang Q, Song R, et al. Non-coding RNAs in depression: promising diagnostic and therapeutic biomarkers[J]. EBioMedicine, 2021, 71: 103569. DOI: 10.1016/j.ebiom.2021.103569.
[16] Fries GR, Zhang W, Benevenuto D, et al. MicroRNAs in Major Depressive Disorder[J]. Adv Exp Med Biol, 2019, 1118: 175-190. DOI: 10.1007/978-3-030-05542-4_9.
[17] Czarny P, Białek K, Ziółkowska S, et al. The Importance of Epigenetics in Diagnostics and Treatment of Major Depressive Disorder[J]. J Pers Med, 2021, 11(3): 167. DOI: 10.3390/jpm11030167.
[18] Wei ZX, Xie GJ, Mao X, et al. Exosomes from patients with major depression cause depressive-like behaviors in mice with involvement of miR-139-5p-regulated neurogenesis[J]. Neuropsychopharmacology, 2020, 45(6): 1050-1058. DOI: 10.1038/s41386-020-0622-2.
[19] Fiori LM, Kos A, Lin R, et al. miR-323a regulates ERBB4 and is involved in depression[J]. Mol Psychiatry, 2021, 26(8): 4191-4204. DOI: 10.1038/s41380-020-00953-7.
[20] Czarny P, Białek K, Ziółkowska S, et al. The Importance of Epigenetics in Diagnostics and Treatment of Major Depressive Disorder[J]. J Pers Med, 2021, 11(3): 167. DOI: 10.3390/jpm11030167.
[21] 张巧丽,过伟,张理义,等. 抑郁症患者药物治疗前后单核细胞中microRNA表达水平变化与抑郁症状的关系[J]. 解放军医学杂志,2015,40(2): 128-132. DOI: 10.11855/j.issn.0577-7402.2015.02.08.
[22] Mora C, Zonca V, Riva MA, et al. Blood biomarkers and treatment response in major depression[J]. Expert Rev Mol Diagn, 2018, 18(6): 513-529. DOI: 10.1080/14737159.2018.1470927.
[23] 邵秋静,冀紫阳,董娇,等. 外周血中微RNA-16和微RNA-124表达水平对抑郁症患者治疗效果的影响[J]. 新乡医学院学报,2022,39(4): 318-322,329. DOI: 10.7683/xxyxyxb.2022.04.004.
[24] Cherian K, Schatzberg AF, Keller J. HPA axis in psychotic major depression and schizophrenia spectrum disorders: Cortisol, clinical symptomatology, and cognition[J]. Schizophrenia Research, 2019, 213: 72-79. DOI: 10.1016/j.schres.2019.07.003.
[25] Shen J, Li Y, Qu C, et al. The enriched environment ameliorates chronic unpredictable mild stress-induced depressive-like behaviors and cognitive impairment by activating the SIRT1/miR-134 signaling pathway in hippocampus[J]. J Affect Disord, 2019, 248: 81-90. DOI: 10.1016/j.jad.2019.01.031.
[26] Li C, Wang F, Miao P, et al. miR-138 Increases Depressive-Like Behaviors by Targeting SIRT1 in Hippocampus[J]. Neuropsychiatr Dis Treat, 2020, 16: 949-957. DOI: 10.2147/NDT.S237558.
[27] Tao Y, Gao K, Shen B, et al. MicroRNA-135b-5p downregulation causes antidepressant effects by regulating SIRT1 expression[J]. Biochem Genet, 2021, 59(6): 1582-1598. DOI: 10.1007/s10528-021-10076-5.
[28] 程艳伟. CircPTK2靶向结合miR-182-5p调控BDNF表达改善抑郁样行为的作用及机制研究[D]. 吉林大学, 2022. DOI: 10.27162/d.cnki.gjlin.2022.007064.
[29] Su M, Hong J, Zhao Y, et al. MeCP2 controls hippocampal brain-derived neurotrophic factor expression via homeostatic interactions with microRNA-132 in rats with depression[J]. Mol Med Rep, 2015, 12(4): 5399-5406. DOI: 10.3892/mmr.2015.4104.
[30] Dwivedi Y. microRNA-124: A putative therapeutic target and biomarker for major depression[J]. Expert Opin Ther Targets, 2017, 21(7): 653-656. DOI: 10.1080/14728222. 2017.1328501.
[31] 田涛,段芙蓉,戴立磊,等. 抑郁症患者BDNF、IL-6及miR-124的表达与疾病严重程度关系研究[J]. 精神医学杂志,2022,35(6):454-457. DOI: 10.3969/j.issn.2095-9346. 2022.06.013.
[32] Roy B, Dunbar M, Shelton RC, et al. Identification of microRNA-124-3p as a putative epigenetic signature of major depressive disorder[J]. Neuropsychopharmacology, 2017, 42(4): 864-875. DOI: 10.1038/npp.2016.175.
[33] Tang C, Hu J. HDAC1-Mediated microRNA-124-5p regulates NPY to affect learning and memory abilities in rats with depression[J]. Nanoscale Res Lett, 2021, 16(1): 28. DOI: 10.1186/s11671-021-03477-3.
[34] Periyasamy P, Thangaraj A, Guo ML, et al. Epigenetic promoter DNA methylation of miR-124 promotes HIV-1 tat-mediated microglial activation via MECP2-STAT3 axis[J]. J Neurosci, 2018, 38(23): 5367-5383. DOI: 10.1523/JNEUROSCI.3474-17.2018.
[35] 曾端. miR-124及其靶基因在抑郁症及抗抑郁疗效中的作用[D]. 上海交通大学, 2020. DOI: 10.27307/d.cnki.gsjtu.2020.000636.
[36] Ding L, Styblo M, Drobna Z, et al. Expression of the Longest RGS4 splice variant in the prefrontal cortex is associated with single nucleotide polymorphisms in schizophrenia patients[J]. Front Psychiatry, 2016, 7: 26. DOI: 10.3389/fpsyt.2016.00026.
[37] Jung S, Son H, Lee DH, et al. Decreased levels of RGS4 in the paraventricular nucleus facilitate GABAergic inhibition during the acute stress response[J]. Biochem Biophys Res Commun, 2016, 472(1): 276-280. DOI: 10.1016/j.bbrc.2016.02.108.
[38] Peña CJ, Nestler EJ. Progress in epigenetics of depression[J]. Prog Mol Biol Transl Sci, 2018, 157: 41-66. DOI: 10.1016/bs.pmbts.2017.12.011.
[39] Fan B, Luk AOY, Chan JCN, et al. MicroRNA and diabetic complications- a clinical perspective[J]. Antioxid Redox Signal, 2018, 29(11): 1041-1063. DOI: 10.1089/ars.2017.7318.

表观遗传与miRNA在抑郁症中的作用

Roles of epigenetics and miRNA in depression

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics